Complete hemograms were evaluated for 57 rats with mononuclear cell leukemia and compared to hemograms obtained from 52 age-and sex-matched nonleukemic rats. All leukemic rats had marked hemolytic anemia and associated spherocytosis, reticulocytosis, anisocytosis, and polychromasia. The anemia vaned with the stage of illness and was more severe in rats with advanced leukemia. Death appeared to be related to anemia. There was a marked neutrophilia with left shift, mild lymphopenia, and moderate to severe thrombocytopenia. Atypical mononuclear cells were detected in circulation in all but three rats. Total white blood cell counts ranged from 5.0-370 X 10' cells/ml. There was an increase in erythrocyte osmotic fragility with separation into two distinct populations of erythrocytes. Eight of nine rats were Coomb's positive indicating an immune-mediated pathogenesis for the anemia. Hemostasis tests revealed a markedly prolonged prothrombin time, hypofibrinogenemia, slightly increased to normal partial thromboplastin time, and undetected fibrin degradation products. These findings suggest significant liver disease associated with the leukemia.
The first reports of mononuclear cell leukemia in Fischer and Wistar rats [4, 51 mentioned hemolytic anemia associated with the disease. It was noted that rats were clinically normal in the early phases, but clinical illness occurred later and anemia was a consistent feature. The duration of illness as measured by appearance of leukemia cells in peripheral blood averaged five weeks. Leukocyte counts ranged from 18,000 to 158,000 cells/pl with 20-90% abnormal cells. Nucleated red cells and marked polychromasia were noted but no further characterization of the anemia was reported. Both previous studies were complicated by the presence of lesions consistent with murine pulmonary mycoplasmosis which may have altered the hematologic response. Our studies were undertaken to more completely characterize the hematologic status of mononuclear cell leukemia in mycoplasma-free rats, to correlate hematologic findings with histological involvement [7] , and to define the pathogenesis of the anemia.
Materials and Methods
Rats came from control groups on two-year chronic studies, were acquired from Charles Rivers Breeding Laboratories (Wilmington, Mass.) and were handled as described previously [7] . Rats were anesthetized with intraperitoneal pentobarbital, opened by midabdominal incision, and bled from the caudal vena cava immediately before necropsy. Impression smears of spleens were made immediately after removal, fixed in absolute methanol, and stained with Wright-Giemsa on an Ames Hema-tek slide stainer (Ames Co., Elkhart, Ind.). Blood smears were prepared from samples in ethylene diamine tetracetate tubes and stained according to the same protocol. Hemogram data were generated with an Ortho-ELT-8 hematology analyzer (Ortho Diagnostics, Rariton, N.J.). Osmotic fragility was determined using a modification of an earlier method [2] . A series of seventeen 16 x 100 mm tubes was set up with sodium chloride concentrations ranging from 1 % to 0% in 0.05% increments. Twenty pl of blood were added to each tube. Tubes were mixed by inversion, incubated at room temperature, and centrifuged for ten minutes at 2,000 rpm. Optical density of the supernatant was determined with a Coleman Junior I1 Spectrophotometer Model 6/20 (Coleman Instruments, Maywood, Ill.) read at 540 nm. Percent hemolysis was calculated by comparing optical density against a distilled water tube. Derivative curves were generated by subtracting the percent hemolysis in each tube from that on the previous tube and plotting the net change. Fibrinogen (Data-Ffl, Dade Diagnostics, Inc., Miami, Fla.), one stage prothrombin time (Thromboplastin-C, Dade Diagnostics, Inc.) and activated partial thromboplastin time (Actin, Dade Diagnostics, Inc.) were determined with a Fibro System Fibrometer (BBL, Div. of Becton, Dickinson and Co., Cockeysville, Md.). Fibrin split products were assayed using the Thrombo-Wellcotest (Burroughs Wellcome Co.. Research Triangle Park, N.C.). Coomb's serum was prepared by absorption of rabbit anti-rat immunoglobulin G (Miles Laboratories, Inc., Elkhart, Ind.) against normal rat erythrocytes and frozen in 125 p1 aliquots. A 2% suspension of rat erythrocytes was made and cells were washed four times in 0.85% phosphate buffered saline. Fifty pl of phosphate buffered saline was placed in each well of a microtiter plate. Fifty p1 of the Coomb's serum was added to the first well and serially diluted twelve times. Twenty pl of washed erythrocytes were added to each well, and the plate was covered and incubated at 37°C and 5% carbon dioxide for one hour before it was removed and read immediately for agglutination against normal control erythrocytes. Leukemic rats were divided into two groups. Rats with mild clinical signs which were euthanatized on the predetermined necropsy date for the study (scheduled sacrifice) were in early stages of leukemia. Moribund rats with severe signs which were euthanatized before scheduled termination (early death) were in the terminal stages of leukemia.
Results
Complete hemograms were done on 57 rats with either clinical signs or palpably enlarged spleens. They were subdivided as follows: 2 1 male and 12 female scheduled sacrifice rats; 15 male and 9 female early death rats. Comparison of these data with values from 52 age-and sex-matched control rats determined to be free of leukemia is presented in tables I and 11. Mean total white cell count was increased markedly in the leukemic rats with a tendency to be higher in early death rats than in scheduled sacrifice rats. The total white cell count was highly variable and ranged from 5.0-370 X lo3. Seven rats (4 scheduled sacrifice and 3 early death) had a total white cell count within the limits of normal. Differential white cell count (table 11) revealed marked neutrophilia that consisted of increases in absolute numbers of both band neutrophils as well as mature segmented neutrophils. There were increases in eosinophils and nucleated erythrocytes but a moderate decrease in lymphocytes. The number of circulating leukemia cells was highly variable but these abnormal cells were present in all but three rats. All rats were determined to have mononuclear cell leukemia by identification of atypical mononuclear cells in splenic impressions. The abnormal mononuclear cell leukemia cells ( fig. 1 ) were 12 to 20 pm in diameter with a cytoplasm to nucleus ratio of 2:13. The nucleus was round to reniform and often indented and eccentrically located ( fig. 1 ). A distinct nucleolus sometimes was observed. The chromatin was dense, coarse, and ropy. The cytoplasm generally was abundant and varied from blue to pale blue. Many cells contained distinct minute red cytoplasmic granules. Cells also frequently had variable numbers of cytoplasmic vacuoles-many of which contained eosinophilic particles. Erythrophagocytosis by tumor cells was observed commonly in peripheral blood smears ( fig. 2) .
Hemograms (table I) confirmed the clinical impression of anemia. There were decreases in erythrocytes, packed cell volume, and hemoglobin values which were more severe in early death rats than scheduled sacrifice rats. The mean corpuscular volume and mean corpuscular hemoglobin were increased markedly with a tendency to be higher in early death than scheduled sacrifice rats. The mean corpuscular hemoglobin concentration was not changed significantly. There also was a marked reticulocytosis which was greater in early death rats. Reticulocyte counts exceeded 80% occasionally and when corrected for anemia demonstrated very high absolute numbers.
Evaluation of erythrocyte morphology revealed a striking anisocytosis and polychromasia with numerous nucleated erythrocytes. Spherocytes were observed commonly but poikilocytes were rare. The shift in erythrocyte size is identified readily in the comparison of normal and mononuclear cell leukemia rat erythrocyte size histograms ( fig. 3 ). This figure demonstrates both the magnitude of the anemia and the shift from a bimodal distribution to a normal distribution in the size range of reticulocytes.
The hemograms also revealed a decrease in mean platelet counts (table I) . There was a distinct trend for thrombocytopenia to be more severe in early death rats than for scheduled sacrifice rats. Platelet counts often were below 200,000 and occasionally below 1 OO,OOO/pl. The observation of macroplatelets on peripheral blood smears was confirmed by platelet size histograms ( fig. 4) . Relative to the normal distribution, the mononuclear cell leukemia platelet histogram reveals a moderate thrombocytopenia and delayed return to baseline in the right hand portion of the platelet size distribution curve identifying a population of large platelets.
Bone marrow activity was assessed by microscopic examination of sections of femur and marrow smears. Histologically, all marrows had increased cellularity compared to age-and sex-matched nonleukemic controls. Numerous megakaryocytes were observed. Both granulocytic and erythrocytic components were active. Myeloid-erythroid ratios were calculated for ten controls, 26 scheduled sacrifice, and eight early death rats. The mean mye1oid:erythroid ratios were: 0.62 f 0.20 for controls, 1.87 f 0.86 for scheduled sacrifice, and 2.88 f 2.33 for early death rats. The means were significantly different (P < 0.05) and demonstrate a progressive increase in the mye1oid:erythroid ratio from normal to early to late in the disease.
Erythrocyte osmotic fragility determination was done on three leukemic rats and compared to osmotic fragility of five normal rats. The three leukemic rats represented a range in severity of anemia that included a slightly anemic rat (packed cell volume = 34%), a moderately anemic rat (packed cell volume = 20%j, and a severely anemic rat (packed cell volume = 11 %) which also was icteric. Figure 5 illustrates the cumulative percent hemolysis in saline solutions of erythrocytes from these three rats compared to the mean calculated for the five normals. All three curves from mononuclear cell leukemia rats were shifted to the left indicating an increased osmotic fragility. Normal rat erythrocytes were 50% hemolyzed in 0.74% saline, while 50% hemolysis occurred at 0.89% and 0.97% in the slightly and markedly anemic rats. Erythrocytes from the icteric rat were 66% hemolyzed in the 1.0% tube. Significant hemolysis occurred in all three mononuclear cell leukemia rats at physiological concentrations of saline. There appears to be linear relationship between erythrocyte hemolysis and either packed cell volume or mean corpuscular volume.
Eight of nine rats were positive for anti-erythrocyte immunoglobulin G with the direct Coomb's test. One rat exhibited autoagglutination at room temperature, and at least six rats had marked rouleaux formation on direct examination. No agglutination occurred when blood was cooled to 4°C. Ten of ten control rats were Coomb's negative with no autoagglutination or rouleaux formation observed.
Hemostasis screens were done on eight early death leukemic rats and five controls. The results of these tests (table 111) indicate a significant prolongation in the prothrombin time in the mononuclear cell leukemia rats. There was a tendency for the partial thromboplastin time to increase in leukemic rats but the mean value was not prolonged significantly. Mean fibrinogen levels were moderately to severely decreased and the platelet counts were decreased markedly in leukemic rats. The assay for fibrin degradation products was negative in all leukemic rats.
Discussion
The results of our studies demonstrate that mononuclear cell leukemia in Fischer rats is associated with the development of an immune-mediated hemolytic anemia. The observed increases in reticulocytes, mean corpuscular volume, and mean corpuscular hemoglobin indicate a regenerative response by the bone marrow or extramedullary sites. This interpretation was confirmed by histological demonstration of increased femoral marrow cellularity. The occurrence of numerous large polychromatophilic erythrocytes on the peripheral smears also is compatible with a regenerative anemia. The degree of reticulocytosis, as high as 95% in some rats, indicates a very intense erythrogenic response even when corrected for anemia. Reticulocytosis appeared to progress in intensity from scheduled sacrifice to early death rats. The appearance of immature erythrocytes in circulation is believed to begin three to four days after red cell destruction and reach a peak between four and six days [6] . This interval is consistent with the duration of the clinical signs of illness in leukemic rats [7] .
The occurrence of severe anemia of sudden onset coupled with a regenerative response and icterus is compatible with a hemolytic mechanism of the anemia. The observation of spherocytes in the peripheral blood, renal hemosiderosis [7] , and hemoglobinuria further support this interpretation. The antibody induced abnormalities of the erythrocytes also was reflected in osmotic fragility studies. The pattern of increased osmotic fragility ( fig. 5 ) was similar to that observed in other species with immune-mediated hemolytic anemia [2, 81. The abnormalities observed in osmotic fragility of erythrocytes in leukemic rats probably reflect several abnormalities including the presence of antibody-induced alterations on cell membranes and release of immature erythrocytes in response to anemia. The presence of such an antibody is indicated by the positive direct Coomb's, spherocytes, autoagglutination, and rouleaux formation. Damage to erythrocyte membranes leading to spherocytosis is probably the most important mechanism leading to increased fragility.
The leukocytosis which was observed primarily was due to the large numbers of atypical mononuclear cells. There was, however, a marked neutrophilia with a left shift that was consistent with the observed increase in bone marrow granulocyte cellularity and the increased mye1oid:erythroid ratio. This response often is seen in hemolytic anemia. Marked lymphoid depletion was observed in the splenic white pulp. It is possible that the decrease in lymphocytes reflects an immunologic alteration occurring either prior to tumorigenesis or as a tumor-mediated event.
Thrombocytopenia occurred in parallel with the anemia. Thrombocytopenia probably accounts for the petechiae observed grossly and microscopically in the brain, lungs and lymph nodes [7] . The numerous megakaryocytes observed in the femoral marrow, observation of giant platelets and shift toward large platelets on the size histogram are all characteristic of increased production by megakaryocytes in response of enhanced platelet destruction [ 11. Several mechanisms of platelet destruction must be considered. Disseminated intravascular coagulation might be initiated by widespread tissue necrosis observed in mononuclear cell leukemia [7] . Sequestration of platelets in an enlarged spleen (hypersplenism) is a possibility due to the consistent occurrence of splenomegaly in mononuclear cell leukemia. Evaluation of hemostasis revealed a consistent and significant (> 2 seconds above control) prolongation of the one-stage prothrombin time and a normal or high normal activated partial thromboplastin time. In addition, there was a moderate to severe fibrinogen deficiency. This pattern is suggestive of disseminated intravascular coagulation but all tested rats were negative for fibrin split products. A likely interpretation of the prolonged prothrombin time and mildly increased partial thromboplastin time is decreased clotting factor production due to liver disease [3] , although disseminated intravascular coagulation cannot be ruled out.
It seems clear that the anemia which occurred in conjunction with mononuclear cell leukemia was regenerative, hemolytic, and associated with the clinical signs of illness observed. The progression in severity from scheduled sacrifice to early death rats and the consistent occurrence of severe anemia in moribund rats suggests that it was associated closely with the cause of death. The hemolysis was immunemediated and involved an immunoglobulin G either directed against erythrocyte membrane antigens or non-specifically coating erythrocytes.
